Susceptibility of influenza viruses circulating in Western Saudi Arabia to neuraminidase inhibitors

References

1. ↵
   1. Hashem AM,
   2. Doyle T,
   3. Van Domselaar G,
   4. Farnsworth A,
   5. Li C,
   6. Wang J,
   7. et al.

   (2011) Recent developments inbioinformatics analyses of influenza A virus surface glycoproteins and their biological relevance. Curr Bioinform 6:415–426.

   OpenUrlCrossRef
2. ↵
   1. Fiore AE,
   2. Fry A,
   3. Shay D,
   4. Gubareva L,
   5. Bresee JS,
   6. Uyeki TM

   (2011) Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 60:1–24.

   OpenUrlCrossRefPubMed
3. ↵
   1. Sheu TG,
   2. Fry AM,
   3. Garten RJ,
   4. Deyde VM,
   5. Shwe T,
   6. Bullion L,
   7. et al.

   (2011) Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010. J Infect Dis 203:13–17.

   OpenUrlCrossRefPubMed
4. ↵
   1. Hurt AC,
   2. Deng YM,
   3. Ernest J,
   4. Caldwell N,
   5. Leang L,
   6. Iannello P,
   7. et al.

   (2011) Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia Pacific region, March 2009 to March 2010. Euro Surveill 16:19770.

   OpenUrlPubMed
5. ↵
   1. Okomo-Adhiambo M,
   2. Nguyen HT,
   3. Abd Elal A,
   4. Sleeman K,
   5. Fry AM,
   6. Gubareva LV

   (2014) Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria. Influenza Other Respir Viruses 8:258–265.

   OpenUrlCrossRefPubMed
6. ↵
   1. Graitcer SB,
   2. Gubareva L,
   3. Kamimoto L,
   4. Doshi S,
   5. Vandermeer M,
   6. Louie J,
   7. et al.

   (2011) Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States. Emerg Infect Dis 17:255–257.

   OpenUrlCrossRefPubMed
7. ↵
   1. Lackenby A,
   2. Moran Gilad J,
   3. Pebody R,
   4. Miah S,
   5. Calatayud L,
   6. Bolotin S,
   7. et al.

   (2011) Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1) 2009 virus, United Kingdom, winter 2010/11. Euro Surveill 13:16.

   OpenUrl
8. ↵
   1. Benkouiten S,
   2. Charrel R,
   3. Belhouchat K,
   4. Drali T,
   5. Nougairede A,
   6. Salez N,
   7. et al.

   (2014) Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg Infect Dis 20:1821–1827.

   OpenUrlCrossRefPubMed
9. ↵
   Centers for Disease Control and Prevention (CDC Real-time RT-PCR (rRT-PCR) Protocol for Detection and Characterization of Influenza, Atlanta, GA, USA) Available from:http://www.cdc.gov/CLSIS. [Accessed 2015 April 5].
10. ↵
    1. World Health Organization

    WHO information for molecular diagnosis of influenza virus - update, Available from:http://www.who.int/influenza/gisrs_laboratory/molecular_diagnosis_influenza_virus_humans_update_201403.pdf. [Updated 2014 March, Accessed 2015 April 5].
11. ↵
    1. World Health Organization

    (2011) Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza: WHO Global Influenza Surveillance Network.: World Health Organization, Available from:http://whqlibdoc.who.int/publications/2011/9789241548090_eng.pdf. [Accessed 2015 April 5].
12. ↵
    Health Protection Agency: Microbiology Services Colindale: Virus Reference Department, influenza MUNANA neuraminidase activity and inhibition assay (fluorescent IC50 assay). SOP NO. V-6815/01-10, Available from:http://www.isirv.org/site/images/stories/avg_documents/Methodology/munana_ic50_sop_for_external.pdf. [Accessed 2015 April 5].
13. ↵
    1. Muthuri SG,
    2. Venkatesan S,
    3. Myles PR,
    4. Leonardi-Bee J,
    5. Al Khuwaitir TS,
    6. Al Mamun A,
    7. et al.

    (2014) Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2:395–404.

    OpenUrl
14. ↵
    1. Ashshi A,
    2. Azhar E,
    3. Johargy A,
    4. Asghar A,
    5. Momenah A,
    6. Turkestani A,
    7. et al.

    (2014) Demographic distribution and transmission potential of influenza A and 2009 pandemic influenza A H1N1 in pilgrims. J Infect Dev Ctries 8:1169–1175.

    OpenUrl
15. ↵
    1. Alsaleem MA

    (2013) Acceptance of H1N1 vaccine among healthcare workers at primary healthcare centres in Abha, KSA. J Egypt Public Health Assoc 88:32–39.

    OpenUrl